berberine and 1-propanol

berberine has been researched along with 1-propanol in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's9 (90.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cicero, AF; Rovati, LC; Setnikar, I1
Affuso, F; Fazio, S; Micillo, F; Ruvolo, A; Saccà, L1
Cacciotti, L; Caminiti, G; Grieco, F; Iaia, L; Marazzi, G; Massaro, R; Pelliccia, F; Rosano, G; Sposato, B; Volterrani, M1
Carlomagno, G; Fazio, S; Mercurio, V; Pirozzi, C; Ruvolo, A1
Bellocchio, A; Bertolini, S; Pisciotta, L1
Casiglia, E; D'Avino, M; Lenti, S; Mazza, A; Ramazzina, E; Schiavon, L; Zuin, M1
Cicero, AF; Colletti, A1
Brea, A; De Castro-Orós, I; Mozas, P; Pocoví, M; Puzo, J; Solà, R; Valls, RM1
Andreozzi, S; Dalmaso, S; Fabrizio, A; Marchitto, N; Mauti, M; Raimondi, G; Sindona, F1
Battista, F; Bonaduce, D; Bosso, G; Brambilla, N; D'Amato, M; Fazio, V; Galletti, F; Gentile, M; Giacovelli, G; Mercurio, V; Pucci, G; Schillaci, G; Vitalini, C1

Reviews

1 review(s) available for berberine and 1-propanol

ArticleYear
Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2016, Oct-15, Volume: 23, Issue:11

    Topics: Berberine; Biological Products; Cholesterol; Clinical Trials as Topic; Dietary Supplements; Drug Therapy, Combination; Dyslipidemias; Fatty Alcohols; Humans; Lipids; Phytosterols; Phytotherapy; Plant Proteins; Silymarin

2016

Trials

7 trial(s) available for berberine and 1-propanol

ArticleYear
Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation.
    Arzneimittel-Forschung, 2007, Volume: 57, Issue:1

    Topics: Anticholesteremic Agents; Berberine; Cholesterol; Dietary Supplements; Drug Combinations; Dyslipidemias; Fatty Alcohols; Female; Folic Acid; Humans; Lipids; Lipoproteins; Liver Function Tests; Male; Middle Aged; Single-Blind Method; Xanthophylls

2007
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2010, Volume: 20, Issue:9

    Topics: Anticholesteremic Agents; Berberine; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Fatty Alcohols; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Placebos; Triglycerides

2010
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
    Advances in therapy, 2011, Volume: 28, Issue:12

    Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Berberine; Biological Products; Blood Glucose; Cholesterol; Dietary Supplements; Fatty Alcohols; Female; Folic Acid; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Medication Adherence; Prospective Studies; Single-Blind Method; Ubiquinone; Xanthophylls

2011
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2012, Volume: 22, Issue:5

    Topics: Anticholesteremic Agents; Berberine; Cardiotonic Agents; Dietary Supplements; Fatty Alcohols; Female; Humans; Insulin Resistance; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Vasodilation; Ventricular Remodeling

2012
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment.
    Lipids in health and disease, 2012, Sep-22, Volume: 11

    Topics: Aged; Anticholesteremic Agents; Azetidines; Berberine; Biological Products; Cholesterol, LDL; Dietary Supplements; Drug Combinations; Drug Therapy, Combination; Ezetimibe; Fatty Alcohols; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Mutation; Receptors, LDL; Statistics, Nonparametric; Triglycerides

2012
Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.
    Advances in therapy, 2015, Volume: 32, Issue:7

    Topics: Berberine; Biological Products; Blood Pressure; Cardiovascular Diseases; Diet; Dietary Supplements; Fatty Alcohols; Female; Folic Acid; Health Behavior; Humans; Hypercholesterolemia; Hypertension; Life Style; Lipids; Male; Middle Aged; Risk Factors; Ubiquinone

2015
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
    Lipids in health and disease, 2019, Mar-18, Volume: 18, Issue:1

    Topics: Adult; Aged; Berberine; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Fatty Alcohols; Female; Humans; Hypertrophy, Left Ventricular; Insulin Resistance; Lipid Metabolism; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Placebos; Treatment Outcome

2019

Other Studies

2 other study(ies) available for berberine and 1-propanol

ArticleYear
Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Adult; Aged; Alleles; Berberine; Cholesterol, LDL; Fatty Alcohols; Female; Heterozygote; Humans; Hypercholesterolemia; Linear Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Proprotein Convertase 9; Proprotein Convertases; Receptors, LDL; Serine Endopeptidases; Xanthophylls

2016
Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome.
    Minerva cardioangiologica, 2018, Volume: 66, Issue:1

    Topics: Berberine; Biological Products; Cassia; Dietary Supplements; Dyslipidemias; Fatty Alcohols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Treatment Outcome; Ubiquinone; Xanthophylls

2018